IL138137A - Cholenic acid amides and pharmaceutical compositions thereof - Google Patents
Cholenic acid amides and pharmaceutical compositions thereofInfo
- Publication number
- IL138137A IL138137A IL13813799A IL13813799A IL138137A IL 138137 A IL138137 A IL 138137A IL 13813799 A IL13813799 A IL 13813799A IL 13813799 A IL13813799 A IL 13813799A IL 138137 A IL138137 A IL 138137A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- acid amides
- cholenic acid
- cholenic
- amides
- Prior art date
Links
- HIAJCGFYHIANNA-QIZZZRFXSA-N 3b-Hydroxy-5-cholenoic acid Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC(O)=O)C)[C@@]1(C)CC2 HIAJCGFYHIANNA-QIZZZRFXSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
- C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9804861.4A GB9804861D0 (en) | 1998-03-06 | 1998-03-06 | Chemical compounds |
| PCT/GB1999/000681 WO1999045024A1 (en) | 1998-03-06 | 1999-03-08 | Cholenic acid amides and pharmaceutical compositions thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL138137A0 IL138137A0 (en) | 2001-10-31 |
| IL138137A true IL138137A (en) | 2005-11-20 |
Family
ID=10828156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13813799A IL138137A (en) | 1998-03-06 | 1999-03-08 | Cholenic acid amides and pharmaceutical compositions thereof |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7235552B1 (cs) |
| EP (1) | EP1060188A1 (cs) |
| JP (1) | JP2002505336A (cs) |
| KR (1) | KR100690037B1 (cs) |
| CN (1) | CN1177860C (cs) |
| AU (1) | AU752992B2 (cs) |
| CA (1) | CA2319763C (cs) |
| CZ (1) | CZ298478B6 (cs) |
| GB (1) | GB9804861D0 (cs) |
| HU (1) | HUP0100854A3 (cs) |
| IL (1) | IL138137A (cs) |
| NO (1) | NO317378B1 (cs) |
| NZ (1) | NZ506139A (cs) |
| WO (1) | WO1999045024A1 (cs) |
| ZA (1) | ZA991841B (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100740354B1 (ko) * | 2000-05-11 | 2007-07-26 | 리서치 인스티튜트 포 메디신 앤드 케미스트리 인코포레이티드 | 2-치환된 프레그나-1,3,5(10)-트리엔 및콜라-1,3,5(10)-트리엔 유도체 및 그의 생물학적 활성 |
| EP1514874A1 (en) * | 2003-07-28 | 2005-03-16 | Schering Aktiengesellschaft | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| WO2009059239A2 (en) * | 2007-11-02 | 2009-05-07 | Mayo Foundation For Medical Education And Research | REDUCING Aβ42 LEVELS AND Aβ AGGREGATION |
| CN108191846B (zh) | 2008-12-04 | 2021-08-20 | 于崇曦 | 高穿透性组合物及其应用 |
| WO2012158794A1 (en) | 2011-05-17 | 2012-11-22 | Wisconsin Alumni Research Foundation | N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses |
| CA2842460C (en) | 2011-07-20 | 2019-08-20 | Brigham Young University | Hydrophobic ceragenin compounds and devices incorporating same |
| US11524015B2 (en) | 2013-03-15 | 2022-12-13 | Brigham Young University | Methods for treating inflammation, autoimmune disorders and pain |
| CN110420211A (zh) | 2013-03-15 | 2019-11-08 | 布莱阿姆青年大学 | 治疗炎症、自身免疫性疾病和疼痛的方法 |
| US11690855B2 (en) | 2013-10-17 | 2023-07-04 | Brigham Young University | Methods for treating lung infections and inflammation |
| US20150203527A1 (en) | 2014-01-23 | 2015-07-23 | Brigham Young University | Cationic steroidal antimicrobials |
| US9434759B1 (en) * | 2015-05-18 | 2016-09-06 | Brigham Young University | Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds |
| US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
| EP3275888B1 (en) * | 2016-07-28 | 2019-09-25 | Council of Scientific & Industrial Research | Progesterone-cationic lipid hybrid as anticancer agent and the process of synthesis thereof |
| US10959433B2 (en) | 2017-03-21 | 2021-03-30 | Brigham Young University | Use of cationic steroidal antimicrobials for sporicidal activity |
| US12186328B2 (en) | 2019-05-23 | 2025-01-07 | Brigham Young University | Use of CSA compounds to stimulate stem cells and hair growth |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1512326A (fr) | 1964-03-27 | 1968-02-09 | Roussel Uclaf | Nouveaux stéroïdes azotés et procédé de préparation |
| US4217288A (en) * | 1977-03-24 | 1980-08-12 | Wisconsin Alumni Research Foundation | Anti-vitamin D compounds |
| US4172076A (en) * | 1977-04-04 | 1979-10-23 | Diamond Shamrock Corporation | Process for preparing steroidal acids and their intermediate derivatives |
| DE2920092A1 (de) * | 1978-05-19 | 1979-11-29 | Wisconsin Alumni Res Found | Antivitamin d-verbindungen und diese enthaltende pharmazeutische zusammensetzungen |
| GB8505862D0 (en) * | 1985-03-07 | 1985-04-11 | Erba Farmitalia | Steroidic 5alpha-reductase inhibitors |
| AU664213B2 (en) * | 1991-11-07 | 1995-11-09 | Research Institute For Medicine And Chemistry Inc. | Vitamin D amide derivatives |
| JP3493037B2 (ja) * | 1991-12-18 | 2004-02-03 | 中外製薬株式会社 | ２２−オキサコレカルシフェロール誘導体とその製造方法 |
| IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
| GB9309422D0 (en) * | 1993-05-07 | 1993-06-23 | Res Inst Medicine Chem | Chemical compounds |
| WO1997042215A1 (en) * | 1996-05-06 | 1997-11-13 | Bionumerik Pharmaceuticals, Inc. | Process for preparing 27-hydroxy cholesterol and related derivatives |
| EP1019059A4 (en) * | 1997-01-24 | 2004-01-14 | Univ California | USE OF FXR, PPAR-ALPHA AND LXR-ALPHA ACTIVATORS TO RESTORE THE BARRIER FUNCTION, TO PROMOTE EPIDERMIS DIFFERENTIATION, AND TO PROLIFERATE |
-
1998
- 1998-03-06 GB GBGB9804861.4A patent/GB9804861D0/en not_active Ceased
-
1999
- 1999-03-08 NZ NZ506139A patent/NZ506139A/xx unknown
- 1999-03-08 KR KR1020007009596A patent/KR100690037B1/ko not_active Expired - Fee Related
- 1999-03-08 ZA ZA9901841A patent/ZA991841B/xx unknown
- 1999-03-08 HU HU0100854A patent/HUP0100854A3/hu unknown
- 1999-03-08 AU AU32675/99A patent/AU752992B2/en not_active Ceased
- 1999-03-08 CN CNB998036935A patent/CN1177860C/zh not_active Expired - Fee Related
- 1999-03-08 EP EP99937931A patent/EP1060188A1/en not_active Withdrawn
- 1999-03-08 JP JP2000534566A patent/JP2002505336A/ja active Pending
- 1999-03-08 CZ CZ20003253A patent/CZ298478B6/cs not_active IP Right Cessation
- 1999-03-08 CA CA002319763A patent/CA2319763C/en not_active Expired - Fee Related
- 1999-03-08 IL IL13813799A patent/IL138137A/xx not_active IP Right Cessation
- 1999-03-08 WO PCT/GB1999/000681 patent/WO1999045024A1/en active IP Right Grant
-
2000
- 2000-08-01 US US09/630,546 patent/US7235552B1/en not_active Expired - Fee Related
- 2000-09-04 NO NO20004399A patent/NO317378B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US7235552B1 (en) | 2007-06-26 |
| CA2319763C (en) | 2008-01-15 |
| EP1060188A1 (en) | 2000-12-20 |
| HUP0100854A2 (hu) | 2001-09-28 |
| ZA991841B (en) | 1999-09-08 |
| CZ298478B6 (cs) | 2007-10-17 |
| JP2002505336A (ja) | 2002-02-19 |
| NO20004399L (no) | 2000-11-03 |
| AU3267599A (en) | 1999-09-20 |
| CN1177860C (zh) | 2004-12-01 |
| WO1999045024A1 (en) | 1999-09-10 |
| CZ20003253A3 (cs) | 2001-03-14 |
| IL138137A0 (en) | 2001-10-31 |
| NO20004399D0 (no) | 2000-09-04 |
| HUP0100854A3 (en) | 2002-09-30 |
| NZ506139A (en) | 2003-06-30 |
| CA2319763A1 (en) | 1999-09-10 |
| AU752992B2 (en) | 2002-10-03 |
| CN1292797A (zh) | 2001-04-25 |
| KR20010041446A (ko) | 2001-05-25 |
| GB9804861D0 (en) | 1998-04-29 |
| NO317378B1 (no) | 2004-10-18 |
| KR100690037B1 (ko) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| HUP0104495A3 (en) | N-substituted 2-cyanopyrrolidines and pharmaceutical compositions containing them | |
| HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
| HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
| IL138573A0 (en) | Amide derivatives and pharmaceutical compositions containing the same | |
| IL135177A0 (en) | Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP9903916A3 (en) | Phosphinic acid amides and pharmaceutical compositions containing the same | |
| HUP0003761A3 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| HUP0202254A3 (en) | Amide substituted imidazoquinolines and pharmaceutical compositions containing them | |
| IL146230A0 (en) | 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| PL345730A1 (en) | Phenoxyacetic acid derivatives and medicinal compositions containing the same | |
| HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
| HUP0002510A3 (en) | Tetrazole derivatives and pharmaceutical compositions containing them | |
| HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
| IL138137A0 (en) | Cholenic acid amides and pharmaceutical compositions thereof | |
| HUP0104985A3 (en) | Pharmaceutical levothyroxine compositions and process for their preparation | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
| IL136612A (en) | Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
| IL125908A0 (en) | Peptides and pharmaceutical compositions comprising same | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |